Bionime Corporation (4737.TW) TAI

62.50

+0.1(+0.16%)

Updated at October 20 11:42AM

Currency In TWD

Valuation

Market Cap3.94B
Enterprise Value6.79B
P/E Ratio-37.08
PEG Ratio-2.33
Price/Sales Ratio2.16
Price/Book Ratio2.24
Enterprise/Revenue3.55
Enterprise/EBITDA71.02

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.06
Operating Margin-0.07

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.06

Income Statement

Revenue1.93B
Revenue/Share28.77
Gross Profit768.38M
EBITDA59.29M
Net Income-127.22M
Diluted EPS-1.91

Balance Sheet

Total Cash374.99M
Total Cash/Share5.55
Total Debt3.03B
Total Debt/Equity1.61
Current Ratio0.8
Book Value Per Share27.98

Price History

52-Week Change-3.27
52-Week High73.9
52-Week Low43.14
Moving Average 50 Days66.2
Moving Average 200 Days61.86

Statistics

Average Volume96,182
Shares Outstanding67.14M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-1.07
Last Split Factor1099:1000
Last Split DateSeptember 08, 2025